Healthpeak Properties (DOC) Q2 2024 earnings summary

Executive summary

• Achieved strong Q2 results, driven by the completed merger with Physicians Realty Trust, expanding the portfolio to 758 properties and realizing $45 million in expected synergies.

• Increased 2024 guidance for the second time, supported by leasing outperformance, same-store operations, and accretive buybacks.

• Net income rose to $145.9 million ($0.21/share) in Q2 2024, up from $51.8 million ($0.09/share) in Q2 2023.

• Enhanced focus on real estate operations, with 70% of staff now directly supporting assets.

• Operating environment impacted by higher interest rates, inflation, and capital market volatility.

Financial highlights

• Q2 2024 FFO as Adjusted: $0.45/share; AFFO: $0.39/share; Nareit FFO: $0.44/share.

• Q2 2024 net income: $145.9 million ($0.21/share); total revenues: $695.5 million.

• Total portfolio same-store growth: 4.5% year-over-year.

• Outpatient medical same-store growth: 3.1%; lab: 3%; CCRC: 21%.

• Net debt to EBITDA at quarter-end: 5.2x; nearly $3 billion in liquidity and $300 million in cash.

Outlook and guidance

• Raised 2024 FFO as Adjusted guidance to $1.77–$1.81/share and AFFO to $1.54–$1.58/share.

• Increased same-store NOI growth guidance to 2.75%–4.25%.

• Management expects cash flows and liquidity to be adequate for the next 12 months.

• Expect continued acceleration in lab and outpatient medical segments in the second half of the year.

• CCRC growth expected to normalize after strong first half.